GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (STU:9U90) » Definitions » Short Percentage of Float

Unity Biotechnology (STU:9U90) Short Percentage of Float


View and export this data going back to 2018. Start your Free Trial

What is Unity Biotechnology Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Unity Biotechnology's Short Percentage of Float

For the Biotechnology subindustry, Unity Biotechnology's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Unity Biotechnology's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Unity Biotechnology's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Unity Biotechnology's Short Percentage of Float falls into.


Unity Biotechnology (STU:9U90) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (STU:9U90) » Definitions » Short Percentage of Float
Comparable Companies
NERV ALGS LTRN NRXP MAIA SEEL LUMO NLTX PTN SIOX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
UBX:USA 9U90:Germany
Address
285 East Grand Avenue, South San Francisco, CA, USA, 94080
Website
https://www.unitybiotechnology.com
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.

Unity Biotechnology (STU:9U90) Headlines

No Headlines